The Role of Oxytocin in the Second Stage of Labor

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Mar 6, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the use of oxytocin, a hormone that helps with contractions, during the second stage of labor, which is when a woman is pushing to deliver her baby. The goal is to see if giving oxytocin at this stage can help improve the delivery process for women experiencing complications during labor.

To participate in this trial, women must be first-time mothers who are at least 37 weeks pregnant and having a single baby. They can join if they are either being induced (having labor started by a doctor) or if labor has started on its own. However, women who are expecting more than one baby, have had previous births, or have certain medical conditions may not be eligible. If you join the trial, you will receive oxytocin during the second stage of labor, and the team will monitor you and your baby closely to understand how it affects the delivery. This trial is currently looking for participants, so if you meet the criteria and are interested, you can discuss it with your healthcare provider.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Nulliparous pregnant women \>/= 37 weeks gestation
• • Singleton pregnancies
• • Admission for induction of labor or spontaneous labor
• Exclusion Criteria:
• • Multiple gestations
• • Multiparous patients
• • Patients with major fetal anomalies
• • Not on oxytocin at the time of complete cervical dilation
• • Patients with fetal head visible at the perineum on diagnosis of complete cervical dilation
• • Maternal medical condition that prohibits prolonged second stage